<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2025//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_250101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39726778</PMID><DateRevised><Year>2025</Year><Month>01</Month><Day>04</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">1663-9812</ISSN><JournalIssue CitedMedium="Print"><Volume>15</Volume><PubDate><Year>2024</Year></PubDate></JournalIssue><Title>Frontiers in pharmacology</Title><ISOAbbreviation>Front Pharmacol</ISOAbbreviation></Journal><ArticleTitle>Efficacy and safety of danshen class injections in the treatment of coronary heart disease: a network meta-analysis.</ArticleTitle><Pagination><StartPage>1487119</StartPage><MedlinePgn>1487119</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1487119</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fphar.2024.1487119</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="UNASSIGNED">Danshen [Salvia miltiorrhiza Bunge (Lamiaceae; Salviae miltiorrhizae radix et rhizoma)] class injections (DSCIs) are widely used in the treatment of coronary heart disease (CHD). However, there are various types of DSCIs available on the market, and it remains uncertain which DSCI has the best clinical efficacy, as well as which one is most effective in regulating inflammatory markers and oxidative stress indicators. The aim of this network meta-analysis (NMA) is to compare the therapeutic effects of different DSCIs to identify the optimal DSCI for the treatment of CHD.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">The databases searched to identify randomized controlled trials (RCTs) of DSCIs for CHD included the China National Knowledge Infrastructure (CNKI), Wanfang Database, China Science and Technology Journal Database (VIP), Chinese Biomedical Literature Database (CBM), PubMed, Web of Science, and Cochrane Library. The search period spanned from the inception of each database up to June 2024. NMA was conducted using RevMan 5.3 and Stata 16.0 software.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">A total of 106 studies including 14,979 patients, involving 10,931 patients, with 5,640 in the experimental group and 5,291 in the control group. And ten DSCIs were extracted, namely: Danhong injection (DH), Danshen injection (DS), Danshenchuanxiongqin injection (DSCXQ), Dansenduofensuanyan injection (DSDFSY), Danshenfen injection (DSFZ), Fufang Danshen injection (FFDS), Guanxinning injection (GXN), Sodium Tanshinone IIA Sulfonate injection (STS), Xiangdan injection (XD), Shenxiongputaotang injection (SXPTT). The results of NMA showed that, XD injection significantly enhances clinical efficacy; STS is more effective in reducing hs-CRP levels; DSDFSY shows better efficacy in decreasing IL-1 and increasing NO levels; DSCXQ has a greater advantage in reducing IL-6 levels; GXN is more effective in regulating SOD levels; and DH is better at reducing MDA levels.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="UNASSIGNED">The combined treatment of DSCIs and WM more significant efficacy in patients with CHD compared to WM treatment alone, including clinical efficacy evaluation, inflammatory markers, and oxidative stress markers. Overall, DSDFSY and DSCXQ show better performance in clinical efficacy evaluation and regulation of inflammatory markers, while DH exhibits a more stable effect in regulating oxidative stress. However, larger sample sizes and high-quality RCTs are still necessary to further compare the various DSCIs.</AbstractText><AbstractText Label="SYSTEMATIC REVIEW REGISTRATION" NlmCategory="UNASSIGNED">[PROSPERO], identifier [CRD42024548928].</AbstractText><CopyrightInformation>Copyright &#xa9; 2024 Dai, Ding, Guo and Wang.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Dai</LastName><ForeName>Shuang</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Ding</LastName><ForeName>Yukun</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Science and Education Departmen, Beijing Fengtai Hospital of Integrated Traditional Chinese and Modern Medicine, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guo</LastName><ForeName>Jianbo</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>LKS Faculty of Medicine, The University of Hong Kong, Pokfulam, Hong Kong SAR, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Xian</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>12</Month><Day>12</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Pharmacol</MedlineTA><NlmUniqueID>101548923</NlmUniqueID><ISSNLinking>1663-9812</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Chinese medicine injection</Keyword><Keyword MajorTopicYN="N">coronary heart disease</Keyword><Keyword MajorTopicYN="N">danshen class injections</Keyword><Keyword MajorTopicYN="N">network meta-analysis</Keyword><Keyword MajorTopicYN="N">randomized controlled trial</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>8</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>11</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>12</Month><Day>27</Day><Hour>6</Hour><Minute>21</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>12</Month><Day>27</Day><Hour>6</Hour><Minute>20</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>12</Month><Day>27</Day><Hour>3</Hour><Minute>59</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>12</Month><Day>12</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39726778</ArticleId><ArticleId IdType="pmc">PMC11669530</ArticleId><ArticleId IdType="doi">10.3389/fphar.2024.1487119</ArticleId><ArticleId IdType="pii">1487119</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Bi C. W., Chen Z. L., Bi C. F. (2011). The effect of Shenxiong glucose injection on high-sensitivity C-reactive protein, endothelin, and quality of life in elderly patients with unstable angina pectoris. Shandong Med. J. 51 (41), 65&#x2013;66.</Citation></Reference><Reference><Citation>Broch K., Anstensrud A. K., Woxholt S., Sharma K., T&#xf8;llefsen I. M., Bendz B., et al. (2021). Randomized trial of interleukin-6 receptor inhibition in patients with acute ST-segment elevation myocardial infarction. J. Am. Coll. Cardiol. 77 (15), 1845&#x2013;1855. 10.1016/j.jacc.2021.02.049</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2021.02.049</ArticleId><ArticleId IdType="pubmed">33858620</ArticleId></ArticleIdList></Reference><Reference><Citation>Byrne R. A., Rossello X., Coughlan J. J., Barbato E., Berry C., Chieffo A., et al. (2023). 2023 ESC Guidelines for the management of acute coronary syndromes. Eur. Heart J. 44 (38), 3720&#x2013;3826. 10.1093/eurheartj/ehad191</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehad191</ArticleId><ArticleId IdType="pubmed">37622654</ArticleId></ArticleIdList></Reference><Reference><Citation>Cai L. L., Li J. H., Xu J. G., Li D. M. (2014). Effect of Danshen ligustrazine for injection on blood rheology, hs-CRP and fat metabolism on elderly patients with unstable angina pectoris. Pract. Pharm. Clin. Remedies 17 (3), 267&#x2013;270.</Citation></Reference><Reference><Citation>Cao X. F., Liu C. R. (2013). The effect of Danhong injection on blood lipids, endothelial function, and inflammatory markers in patients with coronary heart disease and angina pectoris. China Rural. Health, 103.</Citation></Reference><Reference><Citation>Chen F. L., Wang X. L., Ma B. (2020). Evaluation for the treatment effect of salvianolate and its influence on the hemorheology and oxidative stress in angina pectoris patients. Chin. J. Disaster Med. 8 (3), 137&#x2013;141.</Citation></Reference><Reference><Citation>Chen J. H., Han Y., Wang X. F. (2015b). Danhong injection for the treatment of 94 cases of unstable angina pectoris with blood stasis type. Henan Tradit. Chin. Med. 35 (7), 1525&#x2013;1527.</Citation></Reference><Reference><Citation>Chen J. L., Wan J., Wang A. L. (2012). Influence of sodium tanshinon &#x2161;asilate on high sensitivity C-reactive protein and matrix metalloproteinase-9 of patients with unstable angina pectoris. Shandong Med. J. 52 (29), 41&#x2013;42.</Citation></Reference><Reference><Citation>Chen S., Zhang J., Yan F. D., Yan J. F., Yuan B., He S. H. (2009). Changes in serum levels of nitric oxide, endothelin, and vascular endothelial growth factor in patients with stable angina pectoris and the intervention effect of salvianolic acid salts. Chin. J. Clin. Pharmacol. Ther. 14 (10), 1160&#x2013;1163.</Citation></Reference><Reference><Citation>Chen S. L., Huang S. B. (2016a). Effect of Salvia miltiorrhiza on cytokines in patients with unstable angina pectoris. J. Hainan Med. Univ. 22 (8), 744&#x2013;746.</Citation></Reference><Reference><Citation>Chen S. L., Huang S. B. (2016b). Effects of Salvia miltiorrhiza on hemorheology and vascular endothelial function in patients with unstable angina pectoris. J. Hainan Med. Univ. 22 (10), 954&#x2013;956.</Citation></Reference><Reference><Citation>Chen S. Q., Li L. P., Ning P., Wang B. D. (2015a). The therapeutic effect and pharmacological analysis of Danhong injection in the treatment of unstable angina pectoris. J. China Prescr. Drug 13 (07), 37&#x2013;38.</Citation></Reference><Reference><Citation>Chen Y. J., Jian F., Chen Y. K. (2021). Effeet of salvianolate on serum IL-6 and hs-CRP in patients with unstable angina pectoris. Chongqing Med. J. 50 (S1), 28&#x2013;31.</Citation></Reference><Reference><Citation>Cumpston M., Li T., Page M. J., Chandler J., Welch V. A., Higgins J. P., et al. (2019). Updated guidance for trusted systematic reviews: a new edition of the Cochrane Handbook for Systematic Reviews of Interventions. Cochrane Database Syst. Rev. 10 (10), ED000142. 10.1002/14651858.ED000142</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/14651858.ED000142</ArticleId><ArticleId IdType="pmc">PMC10284251</ArticleId><ArticleId IdType="pubmed">31643080</ArticleId></ArticleIdList></Reference><Reference><Citation>Dawuti A., Sun S., Wang R., Gong D., Liu R., Kong D., et al. (2023). Salvianolic acid A alleviates heart failure with preserved ejection fraction via regulating TLR/Myd88/TRAF/NF-&#x3ba;B and p38MAPK/CREB signaling pathways. Biomed. Pharmacother. 168, 115837. 10.1016/j.biopha.2023.115837</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biopha.2023.115837</ArticleId><ArticleId IdType="pubmed">37931518</ArticleId></ArticleIdList></Reference><Reference><Citation>Deng Y., Ng E. S., Kwan Y. W., Lau C. B. S., Cheung D. W. S., Koon J. C. M., et al. (2014). Cerebral vasodilator properties of Danshen and Gegen: a study of their combined efficacy and mechanisms of actions. Phytomedicine 21 (4), 391&#x2013;399. 10.1016/j.phymed.2013.09.016</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.phymed.2013.09.016</ArticleId><ArticleId IdType="pubmed">24192211</ArticleId></ArticleIdList></Reference><Reference><Citation>Du H., Li C., Wang Z., He Y., Wang Y., Zhou H., et al. (2021). Effects of Danhong injection on dyslipidemia and cholesterol metabolism in high-fat diets fed rats. J. Ethnopharmacol. 274, 114058. 10.1016/j.jep.2021.114058</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jep.2021.114058</ArticleId><ArticleId IdType="pubmed">33766756</ArticleId></ArticleIdList></Reference><Reference><Citation>Duan X. L., Ji X. W., Zhang A. Y., Zhang J. G., Zhao C. H., Yang L. L. (2010). The effect of Salvianolate on unstable angina pectoris and its influence on the levels of SOD and MDA. Acta Acad. Med. Weifang 32 (1), 23&#x2013;25.</Citation></Reference><Reference><Citation>Eikelboom J. W., Anand S. S., Malmberg K., Weitz J. I., Ginsberg J. S., Yusuf S. (2000). Unfractionated heparin and low-molecular-weight heparin in acute coronary syndrome without ST elevation: a meta-analysis. Lancet 355 (9219), 1936&#x2013;1942. 10.1016/S0140-6736(00)02324-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(00)02324-2</ArticleId><ArticleId IdType="pubmed">10859038</ArticleId></ArticleIdList></Reference><Reference><Citation>Everett B. M., MacFadyen J. G., Thuren T., Libby P., Glynn R. J., Ridker P. M. (2020). Inhibition of interleukin-1&#x3b2; and reduction in atherothrombotic cardiovascular events in the CANTOS trial. J. Am. Coll. Cardiol. 76 (14), 1660&#x2013;1670. 10.1016/j.jacc.2020.08.011</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2020.08.011</ArticleId><ArticleId IdType="pubmed">33004131</ArticleId></ArticleIdList></Reference><Reference><Citation>Fang Y., Yang K. P., Jin D. (2018). The effects of vascular endothelial growth factor, serum brain natriuretic peptide precursor, and soluble signaling hormone 4D. Mod. J. Integr. Traditional Chin. West. Med. 27 (35), 3964&#x2013;3967.</Citation></Reference><Reference><Citation>Feng Z. H., Ji X. W. (2010). Clinical study of salvianolate in early admission period in patients with unstable angina. J. Liaoning Univ. Traditional Chin. Med. 12 (4), 54&#x2013;56.</Citation></Reference><Reference><Citation>Fibrinolytic Therapy Trialists (FTT) (1994). Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients. Fibrinolytic Therapy Trialists' (FTT) Collaborative Group. Lancet 343 (8893), 311&#x2013;322.</Citation><ArticleIdList><ArticleId IdType="pubmed">7905143</ArticleId></ArticleIdList></Reference><Reference><Citation>Fu T., Jiang C. H. (2015). Effects of Danhong injection on serum sICAM-1 and hs-CRP in patients with unstable angina pectoris. J. Electrocardiol. Circulation 34 (4), 256&#x2013;258, 278.</Citation></Reference><Reference><Citation>Fu Y. C., Meng L. Q. (2011). Clinical observation on the treatment of coronary heart disease and angina pectoris with Guanxinning injection. New Chin. Med. 43 (8), 8&#x2013;9.</Citation></Reference><Reference><Citation>Gao S., Liu Z., Li H., Little P. J., Liu P., Xu S. (2012). Cardiovascular actions and therapeutic potential of tanshinone IIA. Atherosclerosis 220 (1), 3&#x2013;10. 10.1016/j.atherosclerosis.2011.06.041</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.atherosclerosis.2011.06.041</ArticleId><ArticleId IdType="pubmed">21774934</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao W., Shi Y. Y., Suo D. M. (2009). Clinical efficacy observation of Beitong Danhong injection in the treatment of unstable angina pectoris. Liaoning J. Traditional Chin. Med. 36 (2), 235&#x2013;236.</Citation></Reference><Reference><Citation>Gorog D. A., Sweeny J. M., Fuster V. (2009). Antiplatelet drug 'resistance'. Part 2: laboratory resistance to antiplatelet drugs-fact or artifact? Nat. Rev. Cardiol. 6 (5), 365&#x2013;373. 10.1038/nrcardio.2009.13</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrcardio.2009.13</ArticleId><ArticleId IdType="pubmed">19365406</ArticleId></ArticleIdList></Reference><Reference><Citation>Guan J. S., Zhou Y., Miao Z. J., Gao S. Z., Chen J. (2019). Effect of salvianolate on endothelial function and oxidative stress in patients with coronary heart disease. China Pharm. 28 (24), 75&#x2013;77.</Citation></Reference><Reference><Citation>Guo G. l., Li C. H., Sun L. Q. (2016). The effects of visfatin. matrix metalloproteinases-9 and hypersensitive C-reactive protein by the treatment of depside salt from salvia miltiorrhiza in ST-segment elevation myocardial infarction patient. J. Clin. Intern Med. 33 (9), 614&#x2013;616.</Citation></Reference><Reference><Citation>Guo Y., Yang J. H., Cao S. D., Gao C. X., He Y., Wang Y., et al. (2021). Effect of main ingredients of Danhong Injection against oxidative stress induced autophagy injury via miR-19a/SIRT1 pathway in endothelial cells. Phytomedicine 83, 153480. 10.1016/j.phymed.2021.153480</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.phymed.2021.153480</ArticleId><ArticleId IdType="pubmed">33548866</ArticleId></ArticleIdList></Reference><Reference><Citation>Hansson G. K. (2005). Inflammation, atherosclerosis, and coronary artery disease. N. Engl. J. Med. 352 (16), 1685&#x2013;1695. 10.1056/NEJMra043430</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMra043430</ArticleId><ArticleId IdType="pubmed">15843671</ArticleId></ArticleIdList></Reference><Reference><Citation>He S., Chen R., Peng L., Jiang Z., Liu H., Chen Z., et al. (2022). Differential action of pro-angiogenic and anti-angiogenic components of Danhong injection in ischemic vascular disease or tumor models. Chin. Med. 17 (1), 4. 10.1186/s13020-021-00557-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13020-021-00557-5</ArticleId><ArticleId IdType="pmc">PMC8725508</ArticleId><ArticleId IdType="pubmed">34983572</ArticleId></ArticleIdList></Reference><Reference><Citation>Hong Y. D., Wu H., Mo H. H., Li F. Y. (2004). Effeet of xiangdan injection in treating acute coronary syndrome and inflammatory markers. Traditional Chin. Drug Res. Clin. Pharmacol. 15 (6), 425&#x2013;428.</Citation></Reference><Reference><Citation>Hu A. Y., Liu L. (2011). The effect of Danhong injection on vascular endothelial function and inflammatory factors in patients with unstable angina pectoris. Her. Med. 30 (3), 319&#x2013;321.</Citation></Reference><Reference><Citation>Huang D. P. (2017). The therapeutic effect of Danhong injection on unstable angina pectoris patients and its effect on serum CRP, Cys-C, and Hcy. World Clin. Med. 11 (21), 74&#x2013;75.</Citation></Reference><Reference><Citation>Hutton B., Salanti G., Caldwell D. M., Chaimani A., Schmid C. H., Cameron C., et al. (2015). The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations. Ann. Intern Med. 162 (11), 777&#x2013;784. 10.7326/M14-2385</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/M14-2385</ArticleId><ArticleId IdType="pubmed">26030634</ArticleId></ArticleIdList></Reference><Reference><Citation>Huynh T., Perron S., O&#x2019;Loughlin J., Joseph L., Labrecque M., Tu J. V., et al. (2009). Comparison of primary percutaneous coronary intervention and fibrinolytic therapy in ST-segment-elevation myocardial infarction: bayesian hierarchical meta-analyses of randomized controlled trials and observational studies. Circulation 119 (24), 3101&#x2013;3109. 10.1161/CIRCULATIONAHA.108.793745</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.108.793745</ArticleId><ArticleId IdType="pubmed">19506117</ArticleId></ArticleIdList></Reference><Reference><Citation>Ji S. L. (2013). Clinical efficacy analysis of Danshen Chuanxiong Injection in the treatment of acute coronary syndrome. Mod. Diagnosis Treat. 24 (4), 794&#x2013;795.</Citation></Reference><Reference><Citation>Jiang X. (2022). Effect of salvianolate adjuvant therapy on hemodynamics, inflammatory factors and cardiomyocyte apoptosis in patients with unstable angina pectoris. Med. Innovation China 19 (13), 58&#x2013;63.</Citation></Reference><Reference><Citation>Jiang Z. P., Ji X. W., Zhang A. Y., Zhang J. G., Zhao C. H., Chen Y. B., et al. (2012). The effect of salvianolic acid salts on inflammatory response in patients with unstable angina pectoris. Chin. J. Clin. Electron. Ed. 6 (19), 6097&#x2013;6098.</Citation></Reference><Reference><Citation>Jiao W. P., Wang Q. F. (2019). Clinical effect of salvianolate in the treatment of unstable angina pectoris. Clin. Res. Pract. 4 (5), 29&#x2013;30.</Citation></Reference><Reference><Citation>Jin J., Liu L., Du L. J. (2012). The effect of tanshinone IIA on plasma endothelin and nitric oxide levels in patients with unstable angina pectoris. Inf. Traditional Chin. Med. 29 (6), 62&#x2013;63.</Citation></Reference><Reference><Citation>Jing L. X. (2014). Effects of Salvianolate intervention on heart rate turbulence and myocardial injury serum index in patients with unstable angina. Med. J. Chin. People's Health 26 (21), 8&#x2013;10.</Citation></Reference><Reference><Citation>Kaufmann P. A., Gnecchi-Ruscone T., di Terlizzi M., Sch&#xe4;fers K. P., L&#xfc;scher T. F., Camici P. G. (2000). Coronary heart disease in smokers: vitamin C restores coronary microcirculatory function. Circulation 102 (11), 1233&#x2013;1238. 10.1161/01.cir.102.11.1233</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.cir.102.11.1233</ArticleId><ArticleId IdType="pubmed">10982536</ArticleId></ArticleIdList></Reference><Reference><Citation>Ke L., Zhong C., Chen Z., Zheng Z., Li S., Chen B., et al. (2023). Tanshinone I: pharmacological activities, molecular mechanisms against diseases and future perspectives. Phytomedicine 110, 154632. 10.1016/j.phymed.2022.154632</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.phymed.2022.154632</ArticleId><ArticleId IdType="pubmed">36608501</ArticleId></ArticleIdList></Reference><Reference><Citation>Knuuti J., Wijns W., Saraste A., Capodanno D., Barbato E., Funck-Brentano C., et al. (2020). 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes. Eur. Heart J. 41 (3), 407&#x2013;477. 10.1093/eurheartj/ehz425</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehz425</ArticleId><ArticleId IdType="pubmed">31504439</ArticleId></ArticleIdList></Reference><Reference><Citation>Lang X. F. (2012). 60 cases of unstable angina treated with integrated traditional Chinese and Western medicine. Acta Chin. Med. Pharmacol. 40 (6), 96&#x2013;98.</Citation></Reference><Reference><Citation>Li C., Kang D., Wu Y. S. (2008). Clinical research of Danhong injection for amelioration of microcirculation in patients with unstable angina. Clin. J. Med. Officers 36 (3), 402&#x2013;404.</Citation></Reference><Reference><Citation>Li H., Chai H., Wang L. Z., Yang H. Y., Ma D. M. (2009b). Observation of guanxinning injection on antioxidant damage in initial type of exercised angina pectoris. China Med. Her. 30 (24), 24&#x2013;25.</Citation></Reference><Reference><Citation>Li H., Li X. C., Jia X. R., Wei C., Xu Z. R., Huang Y. Q. (2009a). The effect and therapeutic effect of Danhong injection on hypersensitive C-reactive protein in patients with unstable angina pectoris. Shaanxi Med. J. 37 (8), 1054&#x2013;1055.</Citation></Reference><Reference><Citation>Li H., Wang L. Z. (2007). Clinical observation of the anti free radical effect of Guanxinning injection on patients with worsening fatigue angina pectoris. Clin. Med. China 23 (10), 874&#x2013;876.</Citation></Reference><Reference><Citation>Li H., Yang H. Y. (2008). The therapeutic effect and endothelial function of Danhong injection on elderly patients with unstable angina pectoris. Shandong Med. J. 48 (32), 92&#x2013;93.</Citation></Reference><Reference><Citation>Li H. D., Lin X. Y., Liu Q. W., Zhang Y. (2018b). Curative effect of Danhong injection on the clinical symptoms, adverse reactions and electrocardiogram of angina pectoris of coronary heart disease. Int. J. Clin. Exp. Med. 11 (2), 910&#x2013;915.</Citation></Reference><Reference><Citation>Li M., Li H., Liu H., Lai X., Xing W. (2022). Efficacy and safety of eight types Salvia miltiorrhiza injections in the treatment of unstable angina pectoris: a network meta-analysis. Front. Pharmacol. 13, 972738. 10.3389/fphar.2022.972738</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2022.972738</ArticleId><ArticleId IdType="pmc">PMC9574204</ArticleId><ArticleId IdType="pubmed">36263128</ArticleId></ArticleIdList></Reference><Reference><Citation>Li S. M., Shang Q. H., Chen K. J., Hao X. (2014). GW25-e4351 sodium tanshinone IIA sulfate reduces elevated serum high sensitivity C-reactive protein in patients with coronary heart disease: a prospective randomized open-label blinded end point trial. J. Am. Coll. Cardiol. 64 (16), C206. 10.1016/j.jacc.2014.06.956</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2014.06.956</ArticleId></ArticleIdList></Reference><Reference><Citation>Li X., Wang W. B., Cao S. J., Zhang Y. (2018a). The effects of salvianolic acid salts on TNF - alpha, hs - CRP, IL - 1, and cardiac function in patients with unstable angina pectoris. J. Clin. Exp. Med. 17 (5), 499&#x2013;503.</Citation></Reference><Reference><Citation>Li Y. F., Yin G. (2012). The effect of Salvia miltiorrhiza ligustrazine injection in UAP for aged people. Qingdao Med. J. 44 (2), 130&#x2013;132.</Citation></Reference><Reference><Citation>Li Y. H., Ge H. Y. (2011). Observation on the treatment of acute coronary syndrome with Danhong injection. J. Med. Forum 32 (11), 150&#x2013;152.</Citation></Reference><Reference><Citation>Li Y. M., Chen X. H., Li J., Hu J. P., Bian Y. L., Wu Y. J. (2007). Clinical study on danshen injection in the treatment of acute coronary syndrome. Chin. J. Traditional Med. Sci. Technol. 14 (6), 392&#x2013;393.</Citation></Reference><Reference><Citation>Li Z., Zou J., Cao D., Ma X. (2020). Pharmacological basis of tanshinone and new insights into tanshinone as a multitarget natural product for multifaceted diseases. Biomed. Pharmacother. 130, 110599. 10.1016/j.biopha.2020.110599</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biopha.2020.110599</ArticleId><ArticleId IdType="pubmed">33236719</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Z. M., Xu S. W., Liu P. Q. (2018c). Salvia miltiorrhizaBurge (Danshen): a golden herbal medicine in cardiovascular therapeutics. Acta Pharmacol. Sin. 39 (5), 802&#x2013;824. 10.1038/aps.2017.193</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/aps.2017.193</ArticleId><ArticleId IdType="pmc">PMC5943903</ArticleId><ArticleId IdType="pubmed">29698387</ArticleId></ArticleIdList></Reference><Reference><Citation>Liao Y. H., Liu X., Deng Y. M., Hu J. J. (2008). The effect of Danhong injection on serum high-sensitivity C-reactive protein in patients with unstable angina pectoris. China Med. 3 (6), 334&#x2013;335.</Citation></Reference><Reference><Citation>Lin Q. W., Wei Z. B., Yao C. Y., Lu Y. L. (2020). Effect of salvianolic acid salt on endothelial function in patients with coronary atherosclerotic heart disease. Chin. J. Mod. Drug Appl. 14 (21), 147&#x2013;148.</Citation></Reference><Reference><Citation>Lin Y. K., Chen Y. J., Li J. Y., Chen Y. L., He D., Zuo R., et al. (2022). Salvianolic acid A from Danhong Injection induces vasorelaxation by Regulating L-type calcium channel in isolated mouse arteries. J. Ethnopharmacol. 296, 115431. 10.1016/j.jep.2022.115431</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jep.2022.115431</ArticleId><ArticleId IdType="pubmed">35700852</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu B., Wang B. J. (2013). Observation on the therapeutic effect of Danhong injection in the treatment of unstable angina pectoris. Guide China Med. 11 (1), 606&#x2013;607.</Citation></Reference><Reference><Citation>Liu G. D., Xiao G. L. (2014). Effect of the salvia phenolic acid on high sensitivity C reactive protein and hemorheology in patients with unstable angina. J. Emerg. Traditional Chin. Med. 23 (1), 3&#x2013;5.</Citation></Reference><Reference><Citation>Liu J., Li D. D., Dong W., Liu Y. Q., Wu Y., Tang D. X., et al. (2021). Detection of an anti-angina therapeutic module in the effective population treated by a multi-target drug Danhong injection: a randomized trial. Signal Transduct. Target Ther. 26 (1), 329. 10.1038/s41392-021-00741-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41392-021-00741-x</ArticleId><ArticleId IdType="pmc">PMC8410855</ArticleId><ArticleId IdType="pubmed">34471087</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu J. Z., Wang T., Zhao Y. G., Pan Z. X., Yuan X. Q. (2015). The therapeutic effect of Danshen Chuanxiong Injection on elderly patients with unstable angina pectoris and its effects on serum hs-CRP and blood lipids. Pharmacol. Clin. Chin. Materia. 31 (4), 237&#x2013;239.</Citation></Reference><Reference><Citation>Liu L. L., Yan Y. J., Gu S. Z. (2023). Evaluation of the efficacy of salvianolate adjuvant therapy in patients with unstable angina pectoris. Northwest Pharm. J. 38 (4), 169&#x2013;173.</Citation></Reference><Reference><Citation>Liu M. Y. (2017). Study on the effect and therapeutic effect of salvianolic acid salts on hemorheology in elderly patients with unstable angina pectoris. Pract. Clin. J. Integr. Traditional Chin. West. Med. 17 (1), 15&#x2013;16.</Citation></Reference><Reference><Citation>Liu S., Wu J., Zhang D., Tan D. (2018). What are the best Salvia miltiorrhiza injection classes for treatment of unstable angina pectoris? A systematic review and network Meta-analysis. J. Tradit. Chin. Med. 38 (3), 321&#x2013;338. 10.1016/s0254-6272(18)30623-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0254-6272(18)30623-x</ArticleId><ArticleId IdType="pubmed">32185964</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y. F., Xu L. J., Xu Z. X., Zhao W. H., Liu X. T. (2012). Danhong injection in the treatment of 48 cases of unstable angina pectoris with coronary atherosclerotic heart disease. China Pharm. 21 (20), 109&#x2013;110.</Citation></Reference><Reference><Citation>Lu J., Ma P. X. (2023). Observation on the clinical effect of injectable salvianolic acid salts in the treatment of coronary heart disease angina pectoris. Pract. Clin. J. Integr. Traditional Chin. West. Med. 23 (6), 11&#x2013;13.</Citation></Reference><Reference><Citation>Lun J., Ji X. W., Zhang A. Y., Zhao C. H., Zhang J. G., Chen Y. B. (2011). Effect of Salvianolate on unstable angina and its influence on NO and ET. Chin. J. Clin. Ration. Drug Use. 4 (2), 1&#x2013;2.</Citation></Reference><Reference><Citation>Luo X. C., Huang T. (2011). The effect of Danhong injection on vascular endothelial function and cardiac function in unstable angina pectoris. J. Mil. Surg. Southwest China 13 (03), 469&#x2013;470.</Citation></Reference><Reference><Citation>Lv X. S. (2018). Influence of salvianolate on endothelial function and homocysteine level in elderly patients with unstable angina pectoris. J. Electrocardiol. Circulation 37 (2), 117&#x2013;120.</Citation></Reference><Reference><Citation>Ma X., Zhang L., Gao F., Jia W., Li C. (2023). Salvia miltiorrhiza and Tanshinone IIA reduce endothelial inflammation and atherosclerotic plaque formation through inhibiting COX-2. Biomed. Pharmacother. 167, 115501. 10.1016/j.biopha.2023.115501</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biopha.2023.115501</ArticleId><ArticleId IdType="pubmed">37713995</ArticleId></ArticleIdList></Reference><Reference><Citation>Mach F., Baigent C., Catapano A. L., Koskinas K. C., Casula M., Badimon L., et al. (2020). 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk. Eur. Heart J. 41 (1), 111&#x2013;188. 10.1093/eurheartj/ehz455</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehz455</ArticleId><ArticleId IdType="pubmed">31504418</ArticleId></ArticleIdList></Reference><Reference><Citation>Malekmohammad K., Sewell R. D. E., Rafieian-Kopaei M. (2019). Antioxidants and atherosclerosis: mechanistic aspects. Biomolecules 9 (8), 301. 10.3390/biom9080301</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biom9080301</ArticleId><ArticleId IdType="pmc">PMC6722928</ArticleId><ArticleId IdType="pubmed">31349600</ArticleId></ArticleIdList></Reference><Reference><Citation>Mao Y. Y., Wang J. Q., Wang C. X., Wang C. X. (2016). Effect of salvianolate on serum levels of hs-CRP and TNF a in unstable angina patients. Clin. Focus 31 (2), 191&#x2013;192, 197.</Citation></Reference><Reference><Citation>Martin S. S., Blaha M. J., Blankstein R., Agatston A., Rivera J. J., Virani S. S., et al. (2014). Dyslipidemia, coronary artery calcium, and incident atherosclerotic cardiovascular disease: implications for statin therapy from the multi-ethnic study of atherosclerosis. Circulation 129 (1), 77&#x2013;86. 10.1161/CIRCULATIONAHA.113.003625</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.113.003625</ArticleId><ArticleId IdType="pmc">PMC3919521</ArticleId><ArticleId IdType="pubmed">24141324</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehta S. R., Bassand J. P., Chrolavicius S., Diaz R., Eikelboom J. W., Fox K. A., et al. (2010). Dose comparisons of clopidogrel and aspirin in acute coronary syndromes. N. Engl. J. Med. 363 (10), 930&#x2013;942. 10.1056/NEJMoa0909475</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa0909475</ArticleId><ArticleId IdType="pubmed">20818903</ArticleId></ArticleIdList></Reference><Reference><Citation>Mei F. G., Wang Z. L., Zhang Y. Q., Zhao G. (2014). Clinical study on the effect of Danshen Chuanxiong Injection on endothelial function in patients with unstable angina pectoris. Chin. J. Traditional Med. Sci. Technol. 21 (z2), 17.</Citation></Reference><Reference><Citation>Mei F. G., Zhang Y. Q., Wang Z. L., Zhao G. (2006). The effect of Danhong injection on serum hypersensitive C-reactive protein in patients with unstable angina pectoris. Pract. J. Cardiac Cereb. Pneumal Vasc. Dis. 14 (12), 972&#x2013;973.</Citation></Reference><Reference><Citation>Mou L. N. (2011). Clinical observation of sodium tanshinone IIA sulfonate in the treatment of coronary heart disease angina pectoris. Guide China Med. 9 (27), 252&#x2013;253.</Citation></Reference><Reference><Citation>National Center for Cardiovascular Disease (2023). China cardiovascular Health and disease report 2022. Beijing: Science Press.</Citation></Reference><Reference><Citation>National Health Commission of the People's Republic of China (2021). China Health statistics Yearbook 2021. Beijing: Peking Union Medical College Press.</Citation></Reference><Reference><Citation>Neumann F. J., Sousa-Uva M., Ahlsson A., Alfonso F., Banning A. P., Benedetto U., et al. (2019). 2018 ESC/EACTS Guidelines on myocardial revascularization. Eur. Heart J. 40 (2), 87&#x2013;165. 10.1093/eurheartj/ehy394</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehy394</ArticleId><ArticleId IdType="pubmed">30165437</ArticleId></ArticleIdList></Reference><Reference><Citation>Nidorf S. M., Fiolet A. T. L., Mosterd A., Eikelboom J. W., Schut A., Opstal T. S. J., et al. (2020). Colchicine in patients with chronic coronary disease. N. Engl. J. Med. 383 (19), 1838&#x2013;1847. 10.1056/NEJMoa2021372</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2021372</ArticleId><ArticleId IdType="pubmed">32865380</ArticleId></ArticleIdList></Reference><Reference><Citation>Nikolakopoulou A., Mavridis D., Furukawa T. A., Cipriani A., Tricco A. C., Straus S. E., et al. (2018). Living network meta-analysis compared with pairwise meta-analysis in comparative effectiveness research: empirical study. BMJ 360, k585. 10.1136/bmj.k585</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.k585</ArticleId><ArticleId IdType="pmc">PMC5829520</ArticleId><ArticleId IdType="pubmed">29490922</ArticleId></ArticleIdList></Reference><Reference><Citation>Padro T., Manfrini O., Bugiardini R., Canty J., Cenko E., De Luca G., et al. (2020). ESC Working Group on Coronary Pathophysiology and Microcirculation position paper on 'coronary microvascular dysfunction in cardiovascular disease. Cardiovasc Res. 116 (4), 741&#x2013;755. 10.1093/cvr/cvaa003</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cvr/cvaa003</ArticleId><ArticleId IdType="pmc">PMC7825482</ArticleId><ArticleId IdType="pubmed">32034397</ArticleId></ArticleIdList></Reference><Reference><Citation>Pan D. M., Liu Q. P., Yang C. J. (2024). Clinical efficacy and safety analysis of salvianolate in treatment of coronary heart disease. Med. Innovation China 15 (35), 50&#x2013;53.</Citation></Reference><Reference><Citation>Pang Z., Zha G., Xu E. F. (2014). Influence of salvia miltiorrhiza phenolic acid salt on blood rheology and endothelial function in elderly patients with unstable angina. Pract. Geriatr. 17 (1), 38&#x2013;40.</Citation></Reference><Reference><Citation>Peng H. S., Liu C. Y., Yang Y. P., Lai Y. W. (2015). Influence study of danhong injection in the serum GDF-15, hs-CRP and NT-proBNP of unstable angina pectoris patients. China and Foreign Med. Treat. 34 (23), 108&#x2013;110.</Citation></Reference><Reference><Citation>Qi L. P., Wang T. P., Shi X. G., Li Q. (2001). Study on the antioxidant effect of Danshen injection on patients with stable angina pectoris. Acta Univ. Med. Anhui 36 (4), 287&#x2013;288.</Citation></Reference><Reference><Citation>Qiu C. Z., Lu Y. G., Huang J. Z., Chen L. Y., He D. M., Chen L. (2017). Changes and significance of serum inflammatory factors and endothelial cell microparticle levels in unstable angina patients treated with salvianolic acid salts as adjunctive therapy. Shandong Med. J. 57 (7), 52&#x2013;54.</Citation></Reference><Reference><Citation>Qiu D., Wang F., Zhao T. (2018). Treatment effect of salvianolateand its influence on the hemorheology and oxidative stress in angina pectoris patients. Anhui Med. Pharm. J. 22 (1), 147&#x2013;151.</Citation></Reference><Reference><Citation>Qiu Y. H. (2020). Clinical efficacy analysis of salvianolic acid salts in the treatment of stable angina pectoris. Chin. J. Urban Rural Enterp. Hyg. (1), 158&#x2013;159.</Citation></Reference><Reference><Citation>Riemersma R. A. (1996). Coronary heart disease and vitamin E. Lancet 347 (9004), 776&#x2013;777. 10.1016/s0140-6736(96)90861-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0140-6736(96)90861-2</ArticleId><ArticleId IdType="pubmed">8622327</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi Y. P., Liu B. (2012). Efficacy observation of 156 cases of senile unstable angina pectoris treated with danhong injection. World J. Integr. Traditional West. Med. 7 (10), 883&#x2013;886.</Citation></Reference><Reference><Citation>Song G. M., Li Y., Gao Y. (2015). Effect of Salvia TMP on laboratory indicators and its efficacy on patients with unstable angina pectoris. Chin. J. Biochem. Pharm. 35 (12), 102&#x2013;104, 107.</Citation></Reference><Reference><Citation>Song J. J., Yang Y. J., Su T., Zhao Q. X. (2017). Effect of salvia miltiorrhiza injection on unstable angina pectoris, serum inflammatory factors and metabonomics. Zhejiang J. Integr. Traditional Chin. West. Med. 27 (12), 1026&#x2013;1031.</Citation></Reference><Reference><Citation>Song Q. T., Zhang Y. Y., Han X., Zhang Y., Zhang X., Gao Y. G., et al. (2019). Potential mechanisms underlying the protective effects of salvianic acid A against atherosclerosis in vivo and vitro. Biomed. Pharmacother. 109, 945&#x2013;956. 10.1016/j.biopha.2018.10.147</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biopha.2018.10.147</ArticleId><ArticleId IdType="pubmed">30551549</ArticleId></ArticleIdList></Reference><Reference><Citation>Su C. Y., Ming Q. L., Rahman K., Han T., Qin L. P. (2015). Salvia miltiorrhiza: traditional medicinal uses, chemistry, and pharmacology. Chin. J. Nat. Med. 13 (3), 163&#x2013;182. 10.1016/S1875-5364(15)30002-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1875-5364(15)30002-9</ArticleId><ArticleId IdType="pubmed">25835361</ArticleId></ArticleIdList></Reference><Reference><Citation>Su X. M., Zhi X. W., Liu J. X., He Y. J., Ma Y., Wang Y. X. (2011). Impact of danhong injection on paraoxonase 1, superoxide dismutase activity and malondialdehyde levels in aged patients with coronary heart disease. Chin. General Pract. 14 (33), 3804&#x2013;3806.</Citation></Reference><Reference><Citation>Sun K., Fu C., Nie S. H., You Y. (2014). The index and improvement effect of using Danhong injection to patients with atherosclerosis symptoms of coronary heart disease (CHD). Pak J. Pharm. Sci. 27 (5), 1699&#x2013;1704.</Citation><ArticleIdList><ArticleId IdType="pubmed">25262522</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun L., Zhang S. H. (2024). Sixty cases with chronic heart failure treated with shenmai rongxin decoction. Henan Tradit. Chin. Med. 35 (7), 1520&#x2013;1521.</Citation></Reference><Reference><Citation>Tan S. J., Guo H. F., Lu Y. (2009). The effect of salvianolic acid salts on endothelial function in elderly patients with unstable angina pectoris. Pract. Geriatr. 23 (2), 126&#x2013;128.</Citation></Reference><Reference><Citation>Tao L., Song C. Y., Chen D. (2024). Efficacy of salvianolate in the treatment of patients with unstable angina pectoris and its effect on hs - CRP. Chin J Clin. Ration. Drug Use 7 (2), 46&#x2013;47.</Citation></Reference><Reference><Citation>T&#xf6;rnwall M. E., Virtamo J., Korhonen P. A., Virtanen M. J., Taylor P. R., Albanes D., et al. (2004). Effect of alpha-tocopherol and beta-carotene supplementation on coronary heart disease during the 6-year post-trial follow-up in the ATBC study. Eur. Heart J. 25 (13), 1171&#x2013;1178. 10.1016/j.ehj.2004.05.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ehj.2004.05.007</ArticleId><ArticleId IdType="pubmed">15231376</ArticleId></ArticleIdList></Reference><Reference><Citation>Valgimigli M., Bueno H., Byrn R. A., Collet J. P., Costa F., Jeppsson A., et al. (2018). 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS: the Task Force for dual antiplatelet therapy in coronary artery disease of the European Society of Cardiology (ESC) and of the European Association for Cardio-Thoracic Surgery (EACTS). Eur. Heart J. 39 (3), 213&#x2013;260. 10.1093/eurheartj/ehx419</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehx419</ArticleId><ArticleId IdType="pubmed">28886622</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang N., Bi Y. (2017). The effect of salvianolic acid salts on related cytokines in patients with unstable angina pectoris. Mod. J. Integr. Traditional Chin. West. Med. 26 (2), 184&#x2013;186.</Citation></Reference><Reference><Citation>Wang S. (2009). Observation on the therapeutic effect of Danhong injection in the treatment of unstable angina pectoris. Guide China Med. 11 (5), 113.</Citation></Reference><Reference><Citation>Wang S. J., Wang Y. H. (2020). Study on the effect of Danhong injection on endothelial glycocalyx in patients with coronary heart disease. J. Med. Theory Pract. 33 (16), 2648&#x2013;2650.</Citation></Reference><Reference><Citation>Wei J., Wu T., Yang Q., Chen M., Ni J., Huang D. (2011). Nitrates for stable angina: a systematic review and meta-analysis of randomized clinical trials. Int. J. Cardiol. 146 (1), 4&#x2013;12. 10.1016/j.ijcard.2010.05.019</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijcard.2010.05.019</ArticleId><ArticleId IdType="pubmed">20557963</ArticleId></ArticleIdList></Reference><Reference><Citation>Wei Q., Shen X. J. (2014). Effects of tanshinone &#x2161; on clinical symptoms and vascular aging factor in angina pectoris of coronary heart disease patients. J. Basic Chin. Med. 20 (6), 783&#x2013;785.</Citation></Reference><Reference><Citation>Wight L. J., VandenBurg M. J., Potter C. E., Freeth C. J. (1992). A large scale comparative study in general practice with nitroglycerin spray and tablet formulations in elderly patients with angina pectoris. Eur. J. Clin. Pharmacol. 42 (3), 341&#x2013;342. 10.1007/BF00266360</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF00266360</ArticleId><ArticleId IdType="pubmed">1577055</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu J. R., Liu S., Zhang X. M., Zhang B. (2017). Danshen injection as adjuvant treatment for unstable angina pectoris: a systematic review and meta-analysis. Chin. J. Integr. Med. 23 (4), 306&#x2013;311. 10.1007/s11655-016-2272-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11655-016-2272-0</ArticleId><ArticleId IdType="pubmed">27921196</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu X. L., Pei X., Li D. Y., Li J. M., Yang D. Y., Gao Y. L., et al. (2010). Effect of salvianolate on serum cytokins level in elderly patients with unstable angina pectoris. Chin. J. Integr. Med. Cardio-Cerebrovascular Dis. 8 (2), 158&#x2013;160.</Citation></Reference><Reference><Citation>Wu Y. T., Xie L. P., Hua Y., Xu H. L., Chen G. H., Han X., et al. (2021). Tanshinone I inhibits oxidative stress-induced cardiomyocyte injury by modulating Nrf2 signaling. Front. Pharmacol. 12, 644116. 10.3389/fphar.2021.644116</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2021.644116</ArticleId><ArticleId IdType="pmc">PMC8167655</ArticleId><ArticleId IdType="pubmed">34084132</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Z. M., Luo X. Y., Wang S. H. (2012). The therapeutic effect of salvianolic acid salts on unstable angina pectoris and their effects on CRP, NO, and ET-1. Henan Tradit. Chin. Med. 32 (7), 864&#x2013;865.</Citation></Reference><Reference><Citation>Xi H. W., Liu G. F., Yang W. (2015). Influence of Shenxiong glucose injection on heart function, blood lipid and inflammatory factors in patients with unstable angina. J. Liaoning Univ. Traditional Chin. Med. 17 (9), 82&#x2013;84.</Citation></Reference><Reference><Citation>Xia L., Zhang H. L. (2022). Efficacy of salvia polyphenolic acid salt in elderly patients with coronary artery disease and its effect on blood lipids. Med. Innovation China 19 (26), 56&#x2013;59.</Citation></Reference><Reference><Citation>Xie Q. T., Liu J. L., Wang H. R., Yuan S. F., Zhao J., Yang X. H. (2020). Clinical trial of salvianolate in the treatment of patients with angina pectoris. Chin. J. Clin. Pharmacol. 36 (1), 3&#x2013;6.</Citation></Reference><Reference><Citation>Xie S., Cao C. (2011). Affection of hemorrheology and hyper - sensitive C &#x2013; RP of danhong injection on unstable angina. Heilongjiang Med. J. 35 (9), 660&#x2013;662.</Citation></Reference><Reference><Citation>Xu L. J., Liu X. K., Liu Y. F. (2014). Treatment of 46 cases of coronary heart disease and angina pectoris with guanxinning injection. China Pharm. 23 (14), 107.</Citation></Reference><Reference><Citation>Xu Z. J., Hao S. Y. (2022). Effects of salviae miltiorrhizae and ligustrazine hydrochloride injection on cardiovascular function and antioxidant function in patients with unstable angina pectoris of coronary heart disease. Clin. Res. Pract. 7 (10), 122&#x2013;125.</Citation></Reference><Reference><Citation>Yan C. G., Zeng J. Q. (2009). The effect of Danhong injection on vascular endothelial function in patients with unstable angina pectoris. Shandong Med. J. 49 (8), 78&#x2013;79.</Citation></Reference><Reference><Citation>Yang C. P., Shi G. (2009). The effect of Danhong injection on inflammatory factors in patients with unstable angina pectoris. J. Pingxiang Univ. 26 (3), 99&#x2013;101.</Citation></Reference><Reference><Citation>Yang L. L., Ji X. W., Zhang A. Y., Zhang J. G., Duan X. L. (2010). Clinical observation of salvianolic acid injection in the treatment of unstable angina pectoris. Chin. J. Clin. Ration. Drug Use. 3 (2), 1&#x2013;2.</Citation></Reference><Reference><Citation>Yang N., Ren F. X. (2010). Sulfotanshinone sodium for unstable angina pectoris: a study of clinical application. China Mod. Dr. 48 (21), 47&#x2013;49.</Citation></Reference><Reference><Citation>Yao H. (2022). Treatment methods and clinical application analysis of coronary heart disease in elderly people over 60 years old. Med. Health (4), 5&#x2013;8.</Citation></Reference><Reference><Citation>Ye T. H., Li X. H., Zhong Y. T., Chen H. X. (2021). The effect of salvianolic acid salts as adjunctive therapy for coronary heart disease angina pectoris and their impact on oxidative stress. Inner Mongolia. J. Traditional Chin. Med. 40 (1), 58&#x2013;60.</Citation></Reference><Reference><Citation>Yu M. H., Fang S. (2016). Clinical curative effect observation of salvia miltiorrhiza ligustrazine injection in treating angina pectoris of coronary heart disease. Clin. J. Chin. Med. 8 (6), 44&#x2013;45.</Citation></Reference><Reference><Citation>Yu M. K., Jiao L. Q. (2014). Effect of salvianolate injection on plasma high-sensitivity C reactive protein and tumor necrosis factor and soluble cell apoptosis factor in unstable angina patients. Hebei J. Traditional Chin. Med. 36 (1), 11&#x2013;13.</Citation></Reference><Reference><Citation>Yue H. J., Yang P. P., Li L. M. (2023). Effect of salvianolic acid on ischemic cardiomyopathy. Henan Med. Res. 32 (13), 2447&#x2013;2450.</Citation></Reference><Reference><Citation>Zhang B. H. (2011). The effects of Danhong injection on inflammatory factors, thromboxane B2, and hemorheology in patients with unstable angina pectoris. Chin. J. Integr. Med. Cardio-Cerebrovascular Dis. 9 (9), 1055&#x2013;1057.</Citation></Reference><Reference><Citation>Zhang C. J., An Q. H., Zheng Y. M. (2018). Expression and intervention study of NF-&#x3ba;B, TNF-&#x3b1;, IL-1 and IL-6 in patients with unstable angina pectoris. J. Binzhou Med. Univ. 41 (3), 168&#x2013;170.</Citation></Reference><Reference><Citation>Zhang L. L., Jiang N., Qu G., Gao S. S. (2010). A comparative study of three commonly used traditional Chinese medicine preparations combined with conventional Western medicine therapy for the treatment of unstable angina pectoris. Chin. J. Integr. Med. Cardio-Cerebrovascular Dis. 8 (4), 388&#x2013;390.</Citation></Reference><Reference><Citation>Zhang R. H. (2010). Influence of salvianolate on clinical efficacy, endothelial function and C-reactive protein in patients with unstable angina pectoris. Mod. Hosp. 10 (5), 35&#x2013;37.</Citation></Reference><Reference><Citation>Zhang S. G., He L. M., Liu S. Y., Li Q. Y., Tan R. R. (2012). Clinical observation on the efficacy and safety of traditional Chinese medicine for promoting blood circulation and removing blood stasis in the treatment of acute coronary syndrome. China and Foreign Med. Treat. 31 (13).</Citation></Reference><Reference><Citation>Zhang W., Ji N. J., Mei Y. B., Hu C. S. (2015a). The effect of salvianolic acid salts on serum Ang &#x2161;, IL-6, and hs CRP in elderly patients with unstable angina pectoris. Chin. J. Traditional Med. Sci. Technol. 22 (6), 683&#x2013;684.</Citation></Reference><Reference><Citation>Zhang X. Y. (2016). Effect discussion of salvianolic acid on blood lipid and inflammatory factors of patients with unstable angina pectoris of coronary heart disease. World Latest Med. Inf. 16 (59), 13&#x2013;14.</Citation></Reference><Reference><Citation>Zhang Y., Wang H., Cui L. J., Zhang Y. Y., Liu Y., Chu X., et al. (2015b). Continuing treatment with Salvia miltiorrhiza injection attenuates myocardial fibrosis in chronic iron-overloaded mice. PLoS One 10 (4), e0124061. 10.1371/journal.pone.0124061</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0124061</ArticleId><ArticleId IdType="pmc">PMC4388639</ArticleId><ArticleId IdType="pubmed">25850001</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y., Xie Y., Liao X., Jia Q., Chai Y. (2017). A Chinese patent medicine Salvia miltiorrhiza depside salts for infusion combined with conventional treatment for patients with angina pectoris: a systematic review and meta-analysis of randomized controlled trials. Phytomedicine 25, 100&#x2013;117. 10.1016/j.phymed.2017.01.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.phymed.2017.01.002</ArticleId><ArticleId IdType="pubmed">28190464</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Z. J. (2017). The effect of tanshinone IIA sodium sulfonate injection on inflammatory factors in unstable angina pectoris. all Health 11 (2), 130&#x2013;131.</Citation></Reference><Reference><Citation>Zhao B., Wang J., Song Y. B. (2015). Effects of Danhong Iniection on unstable factors and vascular endothelial function of inflammation in patients with angina pectoris. J. Liaoning Univ. Traditional Chin. Med. 17 (9), 182&#x2013;184.</Citation></Reference><Reference><Citation>Zhao H., Zhang Y. C., Pu S. J. (2011). Clinical application and evaluation of Danhong injection for patients with unstable angina. Sichuan J. Anat. 19 (4), 10&#x2013;12.</Citation></Reference><Reference><Citation>Zhou S. N., Guo H. (2018). The effect of salvianolic acid salts in the treatment of coronary heart disease and their impact on ET-1 and NO levels. Laboratory Med. Clin. 15 (11), 1680&#x2013;1683.</Citation></Reference><Reference><Citation>Zhu Q. K. (2019). The effect of salvianolic acid salts as adjunctive therapy for unstable angina on inflammatory response and angina attacks. J. Med. Theory Pract. 32 (13), 2015&#x2013;2016.</Citation></Reference><Reference><Citation>Zhu Y., He Y. H. (2002). Clinical observation of Danshen powder injection in the treatment of unstable angina pectoris. J. Emerg. Traditional Chin. Med. 11 (4), 253&#x2013;254.</Citation></Reference><Reference><Citation>Zou F., Du Q., Zhang Y., Zuo L., Sun Z. (2023). Pseudo-allergic reactions induced by Chinese medicine injections: a review. Chin. Med. 18 (1), 149. 10.1186/s13020-023-00855-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13020-023-00855-0</ArticleId><ArticleId IdType="pmc">PMC10642014</ArticleId><ArticleId IdType="pubmed">37953288</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>